Contribution of Inflammation, Oxidative Stress, and Antioxidants to the Relationship between Sleep Duration and Cardiometabolic Health

Sleep

Volumn 38, Issue 12, 2015, Pages 1905-1912

  Kanagasabai, Thirumagal ^a   Ardern, Chris I ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

antioxidants; cardiometabolic health; indirect mediation effect; inflammation and oxidative stress; sleep duration

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BILIRUBIN; C REACTIVE PROTEIN; CAROTENOID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL; TRIACYLGLYCEROL; URIC ACID; VITAMIN D; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOMETABOLIC RISK; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY PATTERN; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FASTING BLOOD GLUCOSE LEVEL; FEMALE; HOUSEHOLD INCOME; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; METABOLIC SYNDROME X; NUTRITIONAL STATUS; OXIDATIVE STRESS; PHYSICAL ACTIVITY; QUESTIONNAIRE; SLEEP QUALITY; SLEEP TIME; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; AGED; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; HEALTH SURVEY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NUTRITION; PHYSIOLOGY; SEXUAL DEVELOPMENT; SLEEP; TIME FACTOR; UNITED STATES;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CAROTENOIDS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; OXIDATIVE STRESS; SEX CHARACTERISTICS; SLEEP; TIME FACTORS; TRANSGLUTAMINASES; UNITED STATES; URIC ACID; VITAMIN D; WAIST CIRCUMFERENCE;

EID: 85012891354     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.5238     Document Type: Article

References (43)

1. Van Cauter E, Spiegel K, Tasali E, Leproult R. Metabolic consequences of sleep and sleep loss. Sleep Med 2008;9:S23–28.
2. Ju S-Y, Choi W-S. Sleep duration and metabolic syndrome in adult populations: a meta-analysis of observational studies. Nutr Diabetes 2013;3:e65.
3. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer 2008;44:293–7.
4. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5.
5. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003;107:391–7.
6. Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009;3:73–80.
7. Scrivo R, Vasile M, Bartosiewicz I, et al. Inflammation as “common soil” of the multifactorial diseases. Autoimmun Rev 2011;10:369–74.
8. Beydoun MA, Shroff MR, Chen X, Beydoun HA, Wang Y, Zonderman AB. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr 2011;141:903–13.
9. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346–52.
10. De Bona KS, Bonfanti G, Bitencourt PER, et al. Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index. Inflammation 2013;36:1539–47.
11. Bo S, Gambino R, Durazzo M, et al. Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol 2005;11:7109.
12. Oyama J, Yamamoto H, Maeda T, Ito A, Node K, Makino N. Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 2012;35:231–6.
13. Brady EM, Davies MJ, Hall AP, Talbot DC, Dick JL, Khunti K. An investigation into the relationship between sleep-disordered breathing, the metabolic syndrome, cardiovascular risk profiles, and inflammation between South Asians and Caucasians residing in the United Kingdom. Metab Syndr Relat Disord 2012;10:152–8.
14. Svendsen M, Blomhoff R, Holme I, Tonstad S. The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders. Eur J Clin Nutr 2007;61:1301–11.
15. Grebe M, Eisele HJ, Weissmann N, et al. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006;173:897–901.
16. Murri M, Alcázar-Ramírez J, Garrido-Sánchez L, et al. Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apneahypopnea syndrome patients. Transl Res 2009;154:111–21.
17. Sharifian A, Farahani S, Pasalar P, Gharavi M, Aminian O. Shift work as an oxidative stressor. J Circadian Rhythms 2005;3:15.
18. NCHS. NHANES - About the National Health and Nutrition Examination Survey. Available at: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm. Accessed December 27, 2014.
19. NCHS. NHANES - NHANES 2005-2006 - Manuals. Available at: http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/manuals05_06.htm. Accessed December 27, 2014.
20. Tamakoshi A, Ohno Y. Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study, Japan. Sleep 2004;27:51–4.
21. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 2005;28:1289–96.
22. Kanagasabai T, Nie JX, Mason C, et al. Metabolic syndrome and prevalent any-site, prostate, breast and colon cancers in the US adult population: NHANES 1999-2010. J Metab Synd 2014;3:135.
23. Physical activity guidelines for Americans. Washington, DC: US Department of Health and Human Services, 2008.
24. AMA. SI Conversion Calculator - AMA Manual of Style. Available at: http://www.amamanualofstyle.com/page/si-conversion-calculator. Accessed April 12, 2014.
25. Kenny DA. Mediation. 2013. Available at: http://davidakenny.net/. Accessed October 3, 2013.
26. Ohida T, Kamal AM, Uchiyama M, et al. The influence of lifestyle and health status factors on sleep loss among the Japanese general population. Sleep 2001;24:333–8.
27. Lin Q-C, Chen L-D, Yu Y-H, Liu KX, Gao SY. Obstructive sleep apnea syndrome is associated with metabolic syndrome and inflammation. Eur Arch Otorhinolaryngol 2014;271:825–31.
28. Kanbay A, Kaya E, Buyukoglan H, et al. Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. Respir Med 2011;105:637–42.
29. Festa A, D’Agostino R, Tracy RP, et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:1131–7.
30. Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, Fuchs D. Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 2010;17:4511–20.
31. Sluijs I, Beulens JWJ, Grobbee DE, van der Schouw YT. Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middle-aged and elderly men. J Nutr 2009;139:987–92.
32. Johnston CS, Beezhold BL, Mostow B, et al. Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults. J Nutr 2007;137:1757–62.
33. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228–30.
34. Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010;59:242–8.
35. Li Q, Yang Z, Lu B, et al. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 2011;10:72.
36. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42:474–80.
37. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009;27:1948–54.
38. Cheung BM, Ong K-L, Tso AW, et al. Gamma-glutamyl transferase level predicts the development of hypertension in Hong Kong Chinese. Clin Chim Acta 2011;412:1326–31.
39. Ness AR, Chee D, Elliott P. Vitamin C and blood pressure–an overview. J Hum Hypertens 1997;11:343–50.
40. Bates CJ, Walmsley CM, Prentice A, et al. Does vitamin C reduce blood pressure? Results of a large study of people aged 65 or older. J Hypertens 1998;16:925–32.
41. Fotherby MD, Williams JC, Forster LA, Craner P, Ferns GA. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 2000;18:411–5.
42. McCarty DE, Chesson Jr AL, Jain SK, Marino AA. The link between vitaminDmetabolismandsleepmedicine.SleepMedRev2014;18:311–9.
43. Van De Water ATM, Holmes A, Hurley DA. Objective measurements of sleep for non-laboratory settings as alternatives to polysomnography – a systematic review. J Sleep Res 2011;20:183–200.